Weng Chao, Xia Yan
General Surgery, Cancer Center, Department of Vascular Surgery, Affiliated People's Hospital, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
J Fluoresc. 2024 Nov 18. doi: 10.1007/s10895-024-04047-3.
The abdominal aortic aneurysm (AAA) is a dilation of the lower part of the body aorta. AAA has no obvious symptoms in the early stages until the aortic wall ruptures suddenly, resulting in massive blood loss and flow into the abdominal cavity. Currently, there is no effective drug treatment for AAA, and the development of effective drugs is crucial. In this study, a novel approach utilizing chitosan/genipin/zinc oxide (CH/G-ZnO) composite nanoparticles as a drug delivery system is proposed. Compound 1 was loaded onto these nanoparticles to form CH/G-ZnO@1 composite. The composite material exhibited light-triggered and rapid gelation properties, and its structure and performance were comprehensively characterized. Subsequently, by treating vascular smooth muscle cells (VSMCs), we found that CH/G-ZnO@1 was able to significantly reduce metalloproteinase (MMP) and increase the expression of COL4A1, thereby increasing the proliferative activity of VSMCs.
腹主动脉瘤(AAA)是人体主动脉下部的扩张。腹主动脉瘤在早期没有明显症状,直到主动脉壁突然破裂,导致大量失血并流入腹腔。目前,对于腹主动脉瘤尚无有效的药物治疗方法,开发有效的药物至关重要。在本研究中,提出了一种利用壳聚糖/京尼平/氧化锌(CH/G-ZnO)复合纳米颗粒作为药物递送系统的新方法。将化合物1负载到这些纳米颗粒上以形成CH/G-ZnO@1复合物。该复合材料表现出光触发和快速凝胶化特性,并对其结构和性能进行了全面表征。随后,通过处理血管平滑肌细胞(VSMC),我们发现CH/G-ZnO@1能够显著降低金属蛋白酶(MMP)并增加COL4A1的表达,从而增加VSMC的增殖活性。